Engineers Gate Manager LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

104,790

-36.4% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $33,272,501 across 27 Drug Manufacturers - Specialty & Generic names. ESPR ranks #27 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	107,678	$7,737,741
2	NBIX	Neurocrine Biosciences Inc	18,361	$3,094,562
3	LQDA	Liquidia Corp	36,213	$2,887,262
4	UTHR	UNITED THERAPEUTICS Corp	4,658	$2,523,844
5	ELAN	Elanco Animal Health Inc	83,722	$2,060,398
6	HLN	Haleon plc	200,344	$1,869,209
7	BCRX	Biocryst Pharmaceuticals Inc	175,002	$1,750,020
8	PAHC	Phibro Animal Health Corp	52,914	$1,661,499

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	104,790	-36.4%	Shares	Sole	2026-08-14
2026-03-31	—	164,773	+60.3%	Shares	Sole	2026-05-15
2025-09-30	—	102,770	+437.2%	Shares	Sole	2025-11-14
2025-03-31	—	19,131	-64.2%	Shares	Sole	2025-05-15
2024-12-31	—	53,373	+190.2%	Shares	Sole	2025-02-14
2024-09-30	—	18,390	-65.3%	Shares	Sole	2024-11-14
2023-12-31	—	52,932	+9.4%	Shares	Sole	2024-02-14
2023-09-30	—	48,391	-33.5%	Shares	Sole	2023-11-14
2023-06-30	—	72,790	+398.7%	Shares	Sole	2023-08-14
2022-09-30	—	14,596	+15.8%	Shares	Sole	2022-11-14
2021-12-31	—	12,603	-79.3%	Shares	Sole	2022-02-14
2021-09-30	—	60,927	+61.3%	Shares	Sole	2021-11-15
2021-06-30	—	37,776	+14.8%	Shares	Sole	2021-08-16
2021-03-31	—	32,912	+0.6%	Shares	Sole	2021-05-17
2020-12-31	—	32,713	+270.9%	Shares	Sole	2021-02-16
2020-06-30	—	8,820	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.